Magnolia Capital Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,345
Closed -$2.66K 159
2023
Q1
$2.66K Hold
20,345
﹤0.01% 147
2022
Q4
$13K Hold
20,345
0.01% 137
2022
Q3
$9K Buy
20,345
+3,333
+20% +$1.73K 0.01% 125
2022
Q2
$8K Hold
17,012
0.01% 126
2022
Q1
$9K Hold
17,012
﹤0.01% 198
2021
Q4
$11K Hold
17,012
﹤0.01% 204
2021
Q3
$26K Hold
17,012
0.01% 185
2021
Q2
$29K Buy
+17,012
New +$29.3K 0.01% 138
2021
Q1
Sell
-17,012
Closed -$29K 137
2020
Q4
$29K Buy
17,012
+63
+0.4% +$63 0.02% 117
2020
Q3
$12K Sell
16,949
-1,943
-10% -$1.54K 0.01% 105
2020
Q2
$16K Buy
18,892
+7,000
+59% +$3.58K 0.02% 93
2020
Q1
$3K Hold
11,892
0.01% 82
2019
Q4
$5K Buy
+11,892
New +$7.3K ﹤0.01% 96

Other funds holding TMDI

Magnolia Capital Advisors's TMDI Position: Q2 2023 in Review

Magnolia Capital Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q2 2023, closing a stake of 20,345 shares — an estimated $2.66K sold.

Magnolia Capital Advisors first reported a position in TMDI in Q4 2019 and held it in 13 quarters. The position peaked at $29K in Q2 2021. 5 funds tracked by Wall St. Rank hold TMDI as of Q2 2023.

  • Magnolia Capital Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Magnolia Capital Advisors sold 20,345 Titan Medical Inc. Ordinary Shares shares in Q2 2023, an estimated $2.66K.
  • Magnolia Capital Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2019 and held it in 13 quarters.
  • Magnolia Capital Advisors's Titan Medical Inc. Ordinary Shares position peaked at $29K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q2 2023.

Based on Magnolia Capital Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.